CD146-targeted nuclear medicine imaging in cancer: state of the art.

CD146 cancer immunoPET molecular imaging radionuclide

Journal

View (Beijing, China)
ISSN: 2688-268X
Titre abrégé: View (Beijing)
Pays: China
ID NLM: 9918248414606676

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 11 12 2023
pubmed: 11 12 2023
entrez: 11 12 2023
Statut: ppublish

Résumé

The transmembrane glycoprotein adhesion molecule CD146 is overexpressed in a wide variety of cancers. Through molecular imaging, a specific biomarker's expression and distribution can be viewed

Identifiants

pubmed: 38076327
doi: 10.1002/VIW.20220085
pmc: PMC10703309
mid: NIHMS1872657
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009206
Pays : United States

Déclaration de conflit d'intérêts

Conflict of Interest Weibo Cai is a scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc.; a consultant and grantee of Actithera, Inc.; a consultant of Rad Source Technologies, Inc.; a scientific advisor of Portrai, Inc.; and a scientific advisor and stockholder rTR Technovation Corporation. All other authors declare no conflict of interest.

Références

J Biol Chem. 2009 Oct 16;284(42):28845-55
pubmed: 19703903
Cancer Res. 2011 May 15;71(10):3494-504
pubmed: 21467165
Oncol Lett. 2016 Jun;11(6):3702-3708
pubmed: 27284374
Adv Exp Med Biol. 2021;1330:125-137
pubmed: 34339034
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2169-2179
pubmed: 27342417
Anal Cell Pathol. 2003;25(2):77-81
pubmed: 12632016
Mol Pharm. 2017 Oct 2;14(10):3239-3247
pubmed: 28825843
Mol Cancer Ther. 2008 Mar;7(3):569-78
pubmed: 18319332
Anticancer Res. 2012 Mar;32(3):861-4
pubmed: 22399604
Oncol Res. 2018 Apr 10;26(3):431-444
pubmed: 28923134
Nat Commun. 2017 Jun 07;8:15279
pubmed: 28589943
Oncotarget. 2017 Nov 28;8(68):112283-112296
pubmed: 29348825
Handb Clin Neurol. 2016;134:381-97
pubmed: 26948367
Prostate. 2008 Mar 1;68(4):418-26
pubmed: 18196513
J Neurooncol. 2019 Aug;144(1):21-32
pubmed: 31147892
Oncol Lett. 2013 Apr;5(4):1189-1194
pubmed: 23599761
J Nucl Med. 2021 Mar;62(3):372-378
pubmed: 32826320
Nat Commun. 2013;4:2803
pubmed: 24335906
Taiwan J Obstet Gynecol. 2014 Dec;53(4):509-17
pubmed: 25510693
Clin Transl Oncol. 2014 Feb;16(2):178-83
pubmed: 23749325
J Urol. 2011 Apr;185(4):1504-12
pubmed: 21334670
Cell Signal. 2015 Sep;27(9):1694-702
pubmed: 26004137
Int J Cancer. 2011 Nov 15;129(10):2360-9
pubmed: 21207373
Int J Mol Sci. 2012;13(5):6399-6406
pubmed: 22754372
Am J Cancer Res. 2021 Apr 15;11(4):1586-1599
pubmed: 33948375
Bioconjug Chem. 2021 Jul 21;32(7):1306-1314
pubmed: 33475350
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Cancer Res. 2009 Feb 15;69(4):1570-7
pubmed: 19221091
J Exp Clin Cancer Res. 2016 Feb 29;35:38
pubmed: 26928402
Acta Biochim Pol. 2019 Dec 11;66(4):619-625
pubmed: 31826047
Cancer Res. 2016 Apr 15;76(8):2314-26
pubmed: 26921326
Int J Biochem Cell Biol. 2009 Nov;41(11):2163-72
pubmed: 19782948
Gene. 2004 Mar 3;327(2):201-13
pubmed: 14980717
Matrix Biol. 2014 Sep;38:69-83
pubmed: 24951930
Cell Commun Signal. 2017 Nov 9;15(1):45
pubmed: 29121955
Adv Sci (Weinh). 2019 Feb 27;6(9):1801237
pubmed: 31065511
Cancer Cell Int. 2015 Feb 04;15(1):3
pubmed: 25685061
Cancer Sci. 2021 Nov;112(11):4617-4626
pubmed: 34464480
Cancers (Basel). 2018 May 05;10(5):
pubmed: 29734758
Clin Exp Metastasis. 2016 Aug;33(6):609-27
pubmed: 27151304
J BUON. 2019 May-Jun;24(3):1009-1019
pubmed: 31424655
Cell Res. 2015 Mar;25(3):275-87
pubmed: 25656845
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6525-34
pubmed: 26553993
Oncotarget. 2016 Jun 28;7(26):40704-40718
pubmed: 27302922
Biomedicines. 2020 Dec 19;8(12):
pubmed: 33352759
Cancer Res. 2017 Aug 15;77(16):4414-4425
pubmed: 28646020
Mol Pharm. 2016 Jul 5;13(7):2563-70
pubmed: 27280694
Theranostics. 2016 Aug 08;6(11):1918-33
pubmed: 27570560
Int J Cancer. 2015 Jul 1;137(1):50-60
pubmed: 25449773
Melanoma Res. 2014 Aug;24(4):404-7
pubmed: 24743054
Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107):
pubmed: 29038378
Oncogene. 2015 Mar 19;34(12):1584-95
pubmed: 24727891
Adv Sci (Weinh). 2021 Mar 15;8(10):2001879
pubmed: 34026426
Clin Respir J. 2019 Jan;13(1):23-33
pubmed: 30480362
Int J Cancer. 1997 Nov 27;73(5):769-74
pubmed: 9398060
Int Urol Nephrol. 2012 Dec;44(6):1663-9
pubmed: 22826148
Front Bioeng Biotechnol. 2019 Nov 14;7:319
pubmed: 31799244
Oncotarget. 2016 Apr 26;7(17):24677-87
pubmed: 27013581
Gene. 2001 Nov 14;279(1):17-31
pubmed: 11722842
J Clin Oncol. 2010 Sep 1;28(25):3994-4005
pubmed: 20679622
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Mol Carcinog. 2017 Mar;56(3):936-944
pubmed: 27583552
Circ Res. 2010 Jul 9;107(1):66-75
pubmed: 20448216
Elife. 2021 Jan 06;10:
pubmed: 33404012
Cancer Cell Int. 2021 Jun 8;21(1):300
pubmed: 34103063
Cancer Lett. 2017 Feb 1;386:65-76
pubmed: 27838413
Oncogene. 2015 Nov 19;34(47):5781-95
pubmed: 25728681
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):168-183
pubmed: 36063202
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23625-23635
pubmed: 31690663
Protein Cell. 2018 Dec;9(12):1050-1054
pubmed: 29671201
Oncol Lett. 2019 Feb;17(2):2418-2424
pubmed: 30675307
Mol Pharm. 2018 Aug 6;15(8):3434-3441
pubmed: 29889530
J Pathol. 1999 Sep;189(1):4-11
pubmed: 10451481
Protein Cell. 2014 Jun;5(6):445-56
pubmed: 24756564
Gastroenterology. 2022 Mar;162(3):890-906
pubmed: 34883119
Cancer Lett. 2013 Apr 28;330(2):150-62
pubmed: 23266426
Asian Pac J Cancer Prev. 2014;15(1):245-52
pubmed: 24528033
Breast Cancer Res. 2009;11(1):R1
pubmed: 19123925
Cancer Biother Radiopharm. 2013 Jul-Aug;28(6):466-70
pubmed: 23745687
J Transl Med. 2013 Dec 17;11:314
pubmed: 24341512
Antibodies (Basel). 2017 Nov 05;6(4):
pubmed: 31548532
Blood. 2012 Sep 13;120(11):2330-9
pubmed: 22718841
Mol Carcinog. 2016 Nov;55(11):1560-1572
pubmed: 26373617
Front Chem. 2014 Dec 18;2:112
pubmed: 25566530
Oncol Lett. 2019 Feb;17(2):2075-2080
pubmed: 30675274
Neoplasia. 2019 Jul;21(7):627-640
pubmed: 31100639
Cancer Lett. 2018 Aug 28;430:201-214
pubmed: 29777784
Int J Cancer. 2020 Jul 15;147(2):490-504
pubmed: 32020593
Tumour Biol. 2012 Oct;33(5):1619-28
pubmed: 22610942
Oncogene. 2020 Aug;39(33):5536-5552
pubmed: 32616889
Front Oncol. 2021 Dec 08;11:744107
pubmed: 34956870

Auteurs

Qi Yang (Q)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Wenpeng Huang (W)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Jessica C Hsu (JC)

Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States of America.

Lele Song (L)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Xinyao Sun (X)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Cuicui Li (C)

Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China.

Weibo Cai (W)

Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States of America.

Lei Kang (L)

Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.

Classifications MeSH